Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics to Provide HCS Equipment for China s National Center for Drug Screening

NEW YORK, Sep 2 (GenomeWeb News) - Cellomics said today that it is collaborating with the National Center for Drug Screening in Shanghai, China, in the area of high content screening.


Cellomics will serve as a "strategic partner" in the establishment of an HCS program at the center, according to a statement by Ming-Wei Wang, director of the NCDS. Further terms of the agreement were not provided.


The NationalCenter for Drug Screening is affiliated with the Shanghai Institute of Materia Medica at the ChineseAcademy of Sciences.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.